LFWD
Lifeward Ltd.
LFWD's outlook is improving, though it still trails on the overall score.
LLY
Eli Lilly and Company
LLY has the edge over LFWD overall, supported by stronger fundamentals and lower modeled downside.
LFWD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
LFWD's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
LFWD PE Valuation
LFWD has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
LFWD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect LFWD's losses to shrink, with revenue growing.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
LFWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$17.23 | +$20.45 |
| Q1 2026 | -$20.07 | +$16.65 |
| Q4 2025 | -$18.89 | +$21.07 |
| Q3 2025 | -$35.88 | -$9.36 |
| Q2 2025 | -$37.68 | -$4.44 |
| Q1 2025 | -$36.72 | -$2.76 |
| Q4 2024 | -$39.96 | -$8.88 |
| Q3 2024 | -$26.52 | +$3.72 |
LFWD is still losing money, but far less than before: $17.23 per share over the past year, against $364.56 at its worst in late 2019.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over LFWD on earnings quality, reporting a profit while its opponent remains loss making.
LFWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.6M | +16% |
| Q1 2026 | $3.9M | -22% |
| Q4 2025 | $5.1M | -33% |
| Q3 2025 | $6.2M | +1.1% |
| Q2 2025 | $5.7M | -15% |
| Q1 2025 | $5M | -4.7% |
| Q4 2024 | $7.5M | +9.6% |
| Q3 2024 | $6.1M | +39% |
LFWD's revenue is down over the past year, though its latest quarter was up: $7M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -63% | +52 points |
| Q1 2026 | -264% | -167 points |
| Q4 2025 | -101% | +101 points |
| Q3 2025 | -51% | +1.1 points |
| Q2 2025 | -115% | -48 points |
| Q1 2025 | -96% | +27 points |
| Q4 2024 | -202% | -113 points |
| Q3 2024 | -52% | +129 points |
LFWD's operating margin was −63% last quarter, up 52 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over LFWD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over LFWD on profitability, with a higher operating margin.
LFWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6M | -$2.1M |
| Q1 2026 | -$3.7M | +$1.8M |
| Q4 2025 | -$3.6M | +$403K |
| Q2 2025 | -$3.9M | +$1.7M |
| Q1 2025 | -$5.5M | +$2.2M |
| Q4 2024 | -$4M | +$594K |
| Q2 2024 | -$5.6M | -$2.1M |
| Q1 2024 | -$7.7M | -$2.4M |
LFWD has burned cash in almost every quarter: −$17M over the past year, against −$19M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over LFWD on cash generation, producing positive trailing cash flow while its opponent burns cash.
LFWD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +74% | +1.2M shares |
| 1 year | +220% | +1.9M shares |
| 3 years | +295% | +2.1M shares |
| 5 years | +1144% | +2.6M shares |
LFWD has 3M diluted shares, up 220% from a year ago.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over LFWD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
LFWD Net Leverage
LFWD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
LFWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 22.9 | Neutral |
LFWD's weekly RSI is 39 (neutral) and its Stochastic is 23 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
LFWD PE vs Healthcare Sector
LFWD has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
LFWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.11 | 6.4% below |
| 20 week MA | $6.92 | 17% below |
| 50 week MA | $7.03 | 19% below |
| 100 week MA | $10.4 | 45% below |
| 200 week MA | $32.9 | 83% below |
LFWD is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over LFWD on trend strength, trading above more of its moving averages.
LFWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $186.5 | $136.1 | -27% |
| 2021 | $136.1 | $113.4 | -17% |
| 2022 | $113.4 | $65.5 | -42% |
| 2023 | $65.5 | $65.4 | -0.2% |
| 2024 | $65.4 | $24.1 | -63% |
| 2025 | $24.1 | $7.73 | -68% |
| 2026 YTD | $7.73 | $5.72 | -26% |
LFWD has finished every year since 2020 lower, and it's down 26% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over LFWD on returns for 2026, with the stronger performance.